SCHEMBL6930362

SCHEMBL6930362

O=C1N(Cc2ccccc2)NCC1(O)O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ELANE P08246 3/20 0.42
KMT2A Q03164 5/20 0.42
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
MEN1 O00255 4/20 0.41
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
F2 P00734 1/20 0.40
PLG P00747 1/20 0.40
CTSG P08311 1/20 0.40
CMA1 P23946 1/20 0.40
CTRC Q99895 1/20 0.40
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
GAA P10253 2/20 0.39
EPHX2 P34913 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11085801 0.69 DDB1 (0.51) ELANEKMT2ADDB1CRBNMEN1
SCHEMBL2435976 0.68 ELANE (0.51) ELANEKMT2AMEN1GSK3AGSK3B
SCHEMBL6934223 0.68 ELANE (0.44) ELANEKMT2AMEN1F2PLG
SCHEMBL6734920 0.67 GSK3A (0.47) ELANEKMT2ADDB1CRBNMEN1
SCHEMBL6933858 0.67 ELANE (0.42) ELANEKMT2ADDB1CRBNMEN1
SCHEMBL8489655 0.67 GAA (0.50) ELANEKMT2ADDB1CRBNMEN1
SCHEMBL17328481 0.65 KMT2A (0.56) ELANEKMT2ADDB1CRBNMEN1
SCHEMBL15319579 0.65 KMT2A (0.56) ELANEKMT2ADDB1CRBNMEN1
SCHEMBL15374440 0.65 KMT2A (0.56) ELANEKMT2ADDB1CRBNMEN1
SCHEMBL10870338 0.63 ELANE (0.55) ELANEKMT2ADDB1CRBNMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0903342-B1 4,4-Dihydroxypyrazolin-5-one compounds, procedures for their preparation and their use as cosmetics OREAL (FR) 2003-12-17 EP disclosed
EP-0903342-A1 4,4-Dihydroxypyrazolin-5-one compounds, procedures for their preparation and their use as cosmetics L'OREAL (FR) 1999-03-24 EP disclosed